Premium
This is an archive article published on February 13, 2021

Explained: Here’s what to know as India starts second dose of Covid-19 vaccine

The Covid-19 vaccine rollout started 28 days ago, and the two lakh beneficiaries who were given the first shot on Day 1 will be administered with the second dose. 

Vials of Covishield, the Indian version of the AstraZeneca-Oxford vaccine, at the Serum Institute of India in Pune, India. (Reuters Photo)Vials of Covishield, the Indian version of the AstraZeneca-Oxford vaccine, at the Serum Institute of India in Pune, India. (Reuters Photo)

India has administered the Covid-19 vaccine to close to 8 million beneficiaries in the first 28 days. From Saturday, the country began administering the second dose of the Covid-19 vaccine to the priority group of healthcare workers.

Why is India starting the second dose on February 13? 

The majority of vaccines in clinical use require a two-dose schedule to be administered two, three or four weeks apart. They are being administered through the intramuscular route. In India, both Serum Institute’s Covishield and Bharat Biotech’s Covaxin have the same course and schedule: two doses schedule, four weeks apart.

The Covid-19 vaccine rollout started 28 days ago, and the two lakh beneficiaries who were given the first shot on Day 1 will be administered with the second dose.

Story continues below this ad

Will the second dose be administered to every beneficiary on the 28th day? 

No, there is no such mandatory requirement. The second dose can be given anytime between four and six weeks after the first shot.

Which all states and UTs have started the second dose on Saturday? 

At least four states have planned sessions to administer the second dose beginning Saturday. These include Delhi, Gujarat, Himachal Pradesh, and Jammu & Kashmir.

Story continues below this ad

Why is it important to get the second dose? 

According to the Centre’s guidelines, the protective levels of antibodies are generally developed two weeks after receiving the second dose of COVID-19 vaccine. In fact, Prime Minister Narendra Modi, while rolling out the vaccination drive, had urged the beneficiaries to mandatorily complete the two-dose schedule. “You cannot take only one dose and then forget; don’t make such a mistake. And as the experts are saying, between the first and second doses, a gap of about one month will be kept. You have to remember that only two weeks after the second dose, your body will develop the necessary strength against corona,” Modi had said.

How is the second dose drive being planned? 

The Co-WIN system of the Ministry of Health and Family Welfare is designed for end-to-end tracking of COVID-19 vaccines and linking every dose to individual beneficiaries. After all doses of the vaccine are administered, a QR code-based certificate will be sent to the registered mobile number of the beneficiary.  
According to the Centre’s guidelines, after administering the first dose, the vaccination officer ticks the vaccination completion checkbox in the Co-WIN system and the beneficiary will receive an SMS notification with a link for date and time of subsequent dose.

Similarly, on the logistics side, the session sites are calculated in accordance with the number of beneficiaries due for vaccination under the flagship Co-WIN platform. Also, one site will administer only one type of vaccine — and every beneficiary will receive the second dose of the same vaccine.

Story continues below this ad
📣 JOIN NOW 📣: The Express Explained Telegram Channel

Which priority group is being vaccinated at present? 

COVID-19 vaccine is being offered first to healthcare workers and frontline workers. For the population above 50 years of age, followed by the population below 50 years of age with associated comorbidities based on the evolving pandemic situation, the drive is likely to start in March.

Kaunain Sheriff M is an award-winning investigative journalist and the National Health Editor at The Indian Express. He is the author of Johnson & Johnson Files: The Indian Secrets of a Global Giant, an investigation into one of the world’s most powerful pharmaceutical companies. With over a decade of experience, Kaunain brings deep expertise in three areas of investigative journalism: law, health, and data. He currently leads The Indian Express newsroom’s in-depth coverage of health. His work has earned some of the most prestigious honours in journalism, including the Ramnath Goenka Award for Excellence in Journalism, the Society of Publishers in Asia (SOPA) Award, and the Mumbai Press Club’s Red Ink Award. Kaunain has also collaborated on major global investigations. He was part of the Implant Files project with the International Consortium of Investigative Journalists (ICIJ), which exposed malpractices in the medical device industry across the world. He also contributed to an international investigation that uncovered how a Chinese big-data firm was monitoring thousands of prominent Indian individuals and institutions in real time. Over the years, he has reported on several high-profile criminal trials, including the Hashimpura massacre, the 2G spectrum scam, and the coal block allocation case. Within The Indian Express, he has been honoured three times with the Indian Express Excellence Award for his investigations—on the anti-Sikh riots, the Vyapam exam scam, and the abuse of the National Security Act in Uttar Pradesh. ... Read More

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement